Human histocompatibility leukocyte antigen (HLA)-E is a nonclassical major histocompatibility complex (MHC) class I molecule which presents a restricted set of nonameric peptides, derived mainly from the signal sequence of other MHC class I molecules. It interacts with CD94/NKG2 receptors expressed on the surface of natural killer (NK) cells and T cell subsets. Here we demonstrate that HLA-E also presents a peptide derived from the leader sequence of human heat shock protein 60 (hsp60). This peptide gains access to HLA-E intracellularly, resulting in up-regulated HLA-E/hsp60 signal peptide cell-surface levels on stressed cells. Notably, HLA-E molecules in complex with the hsp60 signal peptide are no longer recognized by CD94/NKG2A inhibitory receptors. Thus, during cellular stress an increased proportion of HLA-E molecules may bind the nonprotective hsp60 signal peptide, leading to a reduced capacity to inhibit a major NK cell population. Such stress induced peptide interference would gradually uncouple CD94/NKG2A inhibitory recognition and provide a mechanism for NK cells to detect stressed cells in a peptide-dependent manner.
Skip Nav Destination
Article navigation
2 December 2002
Article|
December 02 2002
A Signal Peptide Derived from hsp60 Binds HLA-E and Interferes with CD94/NKG2A Recognition
Jakob Michaëlsson,
Jakob Michaëlsson
1Microbiology and Tumor Biology Center, Karolinska Institutet, 171 77 Stockholm, Sweden
Search for other works by this author on:
Cristina Teixeira de Matos,
Cristina Teixeira de Matos
1Microbiology and Tumor Biology Center, Karolinska Institutet, 171 77 Stockholm, Sweden
Search for other works by this author on:
Adnane Achour,
Adnane Achour
1Microbiology and Tumor Biology Center, Karolinska Institutet, 171 77 Stockholm, Sweden
Search for other works by this author on:
Lewis L. Lanier,
Lewis L. Lanier
2Department of Microbiology and Immunology and the Cancer Research Institute, University of California, San Francisco, San Francisco, CA 94143
Search for other works by this author on:
Klas Kärre,
Klas Kärre
1Microbiology and Tumor Biology Center, Karolinska Institutet, 171 77 Stockholm, Sweden
Search for other works by this author on:
Kalle Söderström
Kalle Söderström
1Microbiology and Tumor Biology Center, Karolinska Institutet, 171 77 Stockholm, Sweden
Search for other works by this author on:
Jakob Michaëlsson
1Microbiology and Tumor Biology Center, Karolinska Institutet, 171 77 Stockholm, Sweden
Cristina Teixeira de Matos
1Microbiology and Tumor Biology Center, Karolinska Institutet, 171 77 Stockholm, Sweden
Adnane Achour
1Microbiology and Tumor Biology Center, Karolinska Institutet, 171 77 Stockholm, Sweden
Lewis L. Lanier
2Department of Microbiology and Immunology and the Cancer Research Institute, University of California, San Francisco, San Francisco, CA 94143
Klas Kärre
1Microbiology and Tumor Biology Center, Karolinska Institutet, 171 77 Stockholm, Sweden
Kalle Söderström
1Microbiology and Tumor Biology Center, Karolinska Institutet, 171 77 Stockholm, Sweden
Address correspondence to Kalle Söderström, MTC, Karolinska Institutet, Box 280, 171 77 Stockholm, Sweden. Phone: 46-8-7286769; Fax: 46-8-304276; E-mail: [email protected]
Kalle Söderström's present address is Entelos Inc., 4040 Campbell Ave., Menlo Park, CA 94025.
J. Michaëlsson and C. Teixeira de Matos contributed equally to this work.
*
Abbreviations used in this paper: GFP, green fluorescent protein; hsp60, heat shock protein 60; hsp60L, hsp60 leader sequence aa 1-26; hsp60sp, heat shock protein 60 signal peptide QMRPVSRVL; KIR, killer Ig-like receptor.
Received:
May 16 2002
Revision Received:
July 26 2002
Accepted:
September 13 2002
Online ISSN: 1540-9538
Print ISSN: 0022-1007
The Rockefeller University Press
2002
J Exp Med (2002) 196 (11): 1403–1414.
Article history
Received:
May 16 2002
Revision Received:
July 26 2002
Accepted:
September 13 2002
Citation
Jakob Michaëlsson, Cristina Teixeira de Matos, Adnane Achour, Lewis L. Lanier, Klas Kärre, Kalle Söderström; A Signal Peptide Derived from hsp60 Binds HLA-E and Interferes with CD94/NKG2A Recognition . J Exp Med 2 December 2002; 196 (11): 1403–1414. doi: https://doi.org/10.1084/jem.20020797
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement